Preparation, characterization, and in vitro release kinetics of doxorubicin-loaded magnetosomes

J Biomater Appl. 2022 Mar;36(8):1469-1483. doi: 10.1177/08853282211060544. Epub 2021 Nov 30.

Abstract

The doxorubicin (DOX) was successfully coupled to the magnetosomes from Acidithiobacillus ferrooxidans (At. ferrooxidans) by genipin bridging. The parameters (magnetosome concentration, DOX concentration, genipin concentration-, and cross-link time) expected for temperature significantly influenced the coupling rate. Bacterial magnetosome-doxorubicin complexes (BMDCs) were characterized by transmission electron microscope (TEM), particle size analyzer and Fourier transform infrared spectroscopy. Results indicated that BMDCs exhibited a mean particle size of 83.98 mm and displayed a negative charge. The chemical reaction occurring between CO and NH group and the physical adsorption predominated by electrostatic interaction were found to involve in coupling. BMDCs can release 40% of DOX in simulated gastrointestinal conditions within 38 h. Kinetic models including Higuchi, Korsmeyer-Peppas, Zero order, First order, Hixon-Crowell, Baker-Lonsdale, and Weibull and Gompertz were utilized to explore the release mechanism of DOX from BMDCs. All models were found to fit well (r2 ≥ 0.8144) with the release data and the Gompertz was the best fit model (r2 = 0.9742), implying that the complex mechanisms involving Fickian and Gompertz diffusion contributed to the release. These findings suggested that magnetosomes from At. ferrooxidans have great potential applications in biomedical and clinical fields as the carrier of target drug delivery systems in the future.

Keywords: Acidithiobacillus ferrooxidans; characterization; coupling; doxorubicin; magnetosomes; release kinetics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Doxorubicin
  • Drug Carriers / chemistry
  • Drug Delivery Systems
  • Kinetics
  • Magnetosomes* / chemistry
  • Particle Size

Substances

  • Drug Carriers
  • Doxorubicin